Clinical Trial Update: Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension [Phase 2, Phase 3]

View source ↗

Summary

This update notes a double-blind, randomized trial of bosentan for sarcoidosis-associated pulmonary hypertension across Phase 2 and Phase 3, which has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Sarcoidosis

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: University of Cincinnati | Conditions: Sarcoidosis, Pulmonary Arterial Hypertension | Phase 2, Phase 3 | Status: COMPLETED